Search Results - "Bockenstedt, Paula"
-
1
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
Published in Nature communications (23-04-2019)“…Potentiation of neutrophil extracellular trap (NET) release is one mechanism by which antiphospholipid antibodies (aPL Abs) effect thrombotic events in…”
Get full text
Journal Article -
2
Anti–Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2020)“…Objective The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils has recently been recognized to play an important role in…”
Get full text
Journal Article -
3
Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2015)“…Objective Antiphospholipid antibodies (aPL), especially those targeting β2‐glycoprotein I (β2GPI), are well known to activate endothelial cells, monocytes, and…”
Get full text
Journal Article -
4
Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac‐1
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2020)“…Objective While the role of antiphospholipid antibodies in activating endothelial cells has been extensively studied, the impact of these antibodies on the…”
Get full text
Journal Article -
5
Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome
Published in Current opinion in rheumatology (01-05-2019)“…PURPOSE OF REVIEWAlthough antiphospholipid syndrome (APS) is best known for conveying increased risk of thrombotic events and pregnancy morbidity,…”
Get full text
Journal Article -
6
Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome
Published in Annals of the rheumatic diseases (01-02-2017)“…Patients with antiphospholipid syndrome (APS) are at risk for subclinical endothelial injury, as well as accelerated atherosclerosis. In the related disease…”
Get more information
Journal Article -
7
Antiphospholipid syndrome: an update for clinicians and scientists
Published in Current opinion in rheumatology (01-09-2017)“…PURPOSE OF REVIEWAntiphospholipid syndrome (APS) is a leading acquired cause of thrombosis and pregnancy loss. Upon diagnosis (which is unlikely to be made…”
Get full text
Journal Article -
8
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target
Published in JCI insight (21-09-2017)“…Antiphospholipid antibodies, present in one-third of lupus patients, increase the risk of thrombosis. We recently reported a key role for neutrophils -…”
Get full text
Journal Article -
9
Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks
Published in Clinical cancer research (01-02-2010)“…Purpose: Genomic complexity is present in approximately 15% to 30% of all chronic lymphocytic leukemia (CLL) and has emerged as a strong independent predictor…”
Get full text
Journal Article -
10
Thrombocytopenia in Pregnancy
Published in Hematology/oncology clinics of North America (01-04-2011)“…Thrombocytopenia in pregnancy is most frequently a benign process that does not require intervention. However, 35% of cases of thrombocytopenia in pregnancy…”
Get full text
Journal Article -
11
NF1 Inactivation in Adult Acute Myelogenous Leukemia
Published in Clinical cancer research (15-08-2010)“…This study was conducted to identify novel genes with importance to the biology of adult acute myelogenous leukemia (AML). We analyzed DNA from highly purified…”
Get full text
Journal Article -
12
Comparison of characteristics from White‐ and Black‐Americans with venous thromboembolism: A cross‐sectional study
Published in American journal of hematology (01-07-2010)“…When compared with Whites, Black‐Americans may have a 40% higher incidence venous thromboembolism (VTE) incidence. However, whether other VTE characteristics…”
Get full text
Journal Article -
13
Venous thromboembolic disease
Published in Journal of the National Comprehensive Cancer Network (01-07-2011)Get more information
Journal Article -
14
Differences in Thrombotic Risk Factors in Black and White Women with Adverse Pregnancy Outcome
Published in Thrombosis research (01-01-2014)“…Abstract Introduction Black women have an increased risk of adverse pregnancy outcomes and the characteristics of thrombotic risk factors in this population…”
Get full text
Journal Article -
15
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
Published in Journal of the National Comprehensive Cancer Network (01-09-2015)“…The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of venous thromboembolism (VTE) in…”
Get more information
Journal Article -
16
Management of hereditary hypercoagulable disorders
Published in Hematology (2006)“…The clinical management of individuals with hereditary hypercoaguable disorders has evolved from initial broad recommendations of lifelong anticoagulation…”
Get full text
Journal Article -
17
Venous thromboembolic disease
Published in Journal of the National Comprehensive Cancer Network (01-11-2013)“…Venous thromboembolism (VTE) remains a common and life-threatening complication among patients with cancer. Thromboprophylaxis can be used to prevent the…”
Get more information
Journal Article -
18
Venous thromboembolic disease. Clinical practice guidelines in oncology
Published in Journal of the National Comprehensive Cancer Network (01-10-2006)Get more information
Journal Article -
19
Increased adhesive potential of antiphospholipid syndrome neutrophils mediated by beta-2 integrin Mac-1
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2020)Get full text
Journal Article -
20
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
Published in The Lancet. Haematology (01-12-2019)“…Hemophagocytic lymphohistiocytosis is a cytokine-driven inflammatory syndrome that is associated with substantial morbidity and mortality. Overall survival in…”
Get full text
Journal Article